Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA)
According to a large study published in The BMJ , adults with type 2 diabetes who started GLP-1 receptor agonists were more likely to develop alopecia than those taking SGLT-2 inhibitors or DPP-4 inhibitors (1 Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation Go to source) Trusted Source Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation Go to source)
They notice improvement in mood within weeks of starting treatment
Results of experimental and clinical investigations demonstrated the effects of the synthetic peptide on the course of retinitis pigmentosa, a degenerative process of the retina resulting from disturbed metabolism of specific proteins in the pigmented epithelium and other retinal layers [38]
Seamlessly adapts to pilot experiments, batch testing, and multi-round validation workflows across all scenarios
